Yoona Yang

Yoona Yang

Auto-generated profile, based on publicly available information

Yoona Yang

Cedars-Sinai Medical Center 3 Center for Bioinformatics and Functional Genomics Los Angeles, California

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2021 in Science Advances
Verified
Journal Article
Open access
ZYZvi Yaari
Zvi Yaari
YYYoona Yang
Yoona Yang
EAElana Apfelbaum
Elana Apfelbaum
CCChristian Cupo
Christian Cupo
ASAlex H. Settle
Alex H. Settle
DHDaniel A. Heller
Daniel A. Heller
Machine learning–enabled perception-based detection of protein biomarkers was achieved in gynecologic cancer patient biofluids.

9 October 2024 in Nature
Verified
Journal Article
Open access
PDF file
ASAmy E. Schade
Amy E. Schade
Naiara PerurenaNaiara Perurena
Naiara Perurena
YYYoona Yang
Yoona Yang
CRCarrie L. Rodriguez
Carrie L. Rodriguez
AKAnjana Krishnan
Anjana Krishnan
KCKaren Cichowski
Karen Cichowski
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and has the highest rate of recurrence1. The predominant standard of care for advanced TNBC is systemic chemotherapy with or without immunotherapy; however, responses are typically short lived1,2. Thus, there is an urgent need to develop more effective treatments. Components of the PI3K pathway represent plausible therapeutic targets; more than 70% of TNBCs have alterations in PIK3CA, AKT1 or PTEN3,4,5,6. However, in contrast to hormone-receptor-positive tumours, it is still unclear whether or how triple-negative disease will respond to PI3K pathway inhibitors7. Here we describe a promising AKT-inhibitor-based therapeutic combination for TNBC. Specifically, we show that AKT inhibitors synergize with agents that suppress the histone methyltransferase EZH2 and promote robust tumour regression in multiple TNBC models in vivo. AKT and EZH2 inhibitors exert these effects by first cooperatively driving basal-like TNBC cells into a more differentiated, luminal-like state, which cannot be effectively induced by either agent alone. Once TNBCs are differentiated, these agents kill them by hijacking signals that normally drive mammary gland involution. Using a machine learning approach, we developed a classifier that can be used to predict sensitivity. Together, these findings identify a promising therapeutic strategy for this highly aggressive tumour type and illustrate how deregulated epigenetic enzymes can insulate tumours from oncogenic vulnerabilities. These studies also reveal how developmental tissue-specific cell death pathways may be co-opted for therapeutic benefit.

6 January 2023 in The Journal of Physical Chemistry A
Verified
Journal Article
Closed access
JZJudit Zádor
Judit Zádor
CMCarles Martí
Carles Martí
RVRuben Van de Vijver
Ruben Van de Vijver
SJSommer L. Johansen
Sommer L. Johansen
YYYoona Yang
Yoona Yang
HNHabib N. Najm
Habib N. Najm

10 January 2019 in npj Computational Materials
Verified
Journal Article
Open access
PDF file
YYYoona Yang
Yoona Yang
MZMing Zheng
Ming Zheng
AJAnand Jagota
Anand Jagota
DNA/single-wall carbon nanotube (SWCNT) hybrids have enabled many applications because of their special ability to disperse and sort SWCNTs by their chirality and handedness. Much work has been done to discover sequences which recognize specific chiralities of SWCNT, and significant progress has been made in understanding the underlying structure and thermodynamics of these hybrids. Nevertheless, de novo prediction of recognition sequences remains essentially impossible and the success rate for their discovery by search of the vast single-stranded DNA library is very low. Here, we report an effective way of predicting recognition sequences based on machine learning analysis of existing experimental sequence data sets. Multiple input feature construction methods (position-specific, term-frequency, combined or segmented term frequency vector, and motif-based feature) were used and compared. The transformed features were used to train several classifier algorithms (logistic regression, support vector machine, and artificial neural network). Trained models were used to predict new sets of recognition sequences, and consensus among a number of models was used successfully to counteract the limited size of the data set. Predictions were tested using aqueous two-phase separation. New data thus acquired were used to retrain the models by adding an experimentally tested new set of predicted sequences to the original set. The frequency of finding correct recognition sequences by the trained model increased to >50% from the ~10% success rate in the original training data set.

25 February 2022 in ACS Nano
Verified
Journal Article
Closed access
ZLZhiwei Lin
Zhiwei Lin
YYYoona Yang
Yoona Yang
AJAnand Jagota
Anand Jagota
MZMing Zheng
Ming Zheng

1 April 2020 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
YYYoona Yang
Yoona Yang
ASArjun Sharma
Arjun Sharma
GNGuillaume Noetinger
Guillaume Noetinger
MZMing Zheng
Ming Zheng
AJAnand Jagota
Anand Jagota